DrugPatentWatch Database Preview
Sagent Pharms Company Profile
» See Plans and Pricing
What is the competitive landscape for SAGENT PHARMS, and what generic and branded alternatives to SAGENT PHARMS drugs are available?
SAGENT PHARMS has seventy-one approved drugs.
There is one tentative approval on SAGENT PHARMS drugs.
Summary for Sagent Pharms
| US Patents: | 0 |
| Tradenames: | 56 |
| Ingredients: | 54 |
| NDAs: | 71 |
Drugs and US Patents for Sagent Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sagent Pharms Inc | OCTREOTIDE ACETATE | octreotide acetate | INJECTABLE;INJECTION | 091041-002 | Nov 12, 2013 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | DESMOPRESSIN ACETATE | desmopressin acetate | INJECTABLE;INJECTION | 204695-001 | Aug 22, 2017 | AP | RX | No | No | Start Trial | Start Trial | ||||
| Sagent Pharms Inc | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 204693-002 | Mar 7, 2018 | AP | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
